Sponsor
Instituto Mexicano del Seguro Social
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Instituto Mexicano del Seguro Social appears in 50 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
50 shownEffect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery.NCT07073846 · lead sponsor · 2025-10-06
RECRUITINGEffectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Compared With Darunavir/Cobicistat Plus Tenofovir Alafenamide/Emtricitabine in Virologically Suppressed People Living With HIV at 24 and 48 Weeks of Follow-upNCT07678268 · lead sponsor · 2025-07-10
RECRUITINGIndocyanine Green Fluorescence Angiography (ICG-FA) in Revisional Bariatric SurgeryNCT07000539 · lead sponsor · 2025-05-06
RECRUITINGSafety, Tolerability and Effectiveness of DTG/3TC vs BIC/TAF/FTC in PWH Without Antiretroviral ExperienceNCT07031063 · lead sponsor · 2025-04-01
RECRUITINGCognitive Intervention for Cognitive ImpairmentNCT07747675 · lead sponsor · 2026-08-03
NOT_YET_RECRUITINGCoronary Artery Calcium Score in HIV Mexican Population (The CACsHIVMex Study)NCT07662161 · lead sponsor · 2026-07-01
NOT_YET_RECRUITINGPrimary Prostatic Lymphoma on a 66 Year-old Male in Mexico.NCT07134504 · lead sponsor · 2025-07-20
COMPLETEDEffect of Dolutegravir Compared With Darunavir/Cobicistat on the Severity of Neuropsychiatric Effects al 12 Weeks in Antirretroviral Treatment-Naive Adults.NCT06787976 · lead sponsor · 2025-06-19
UNKNOWNTranscranial Magnetic Stimulation in Depression.NCT07638202 · lead sponsor · 2025-01-06
COMPLETEDImpact of a Playful Family Education Strategy With ICT on Childhood Obesity PreventionNCT06486493 · lead sponsor · 2025-01-01
NOT_YET_RECRUITINGTherapeutic Adherence in Type 2 DiabetesNCT07837856 · lead sponsor · 2024-11-30
COMPLETED"Residual Kidney Function and Oxidative Stress in Incremental vs Standard Peritoneal Dialysis (2 Mexican Centers)"NCT07338435 · lead sponsor · 2024-11-01
ACTIVE_NOT_RECRUITINGChange in Body Weight and BMI in PWH with DOR/3TC/TDF Compared with INSTINCT06602622 · lead sponsor · 2024-08-14
UNKNOWNMandatory Hiatoplasty in Sleeve Gastrectomy for Gastro-Esophageal Reflux DiseaseNCT06316167 · lead sponsor · 2024-03-01
UNKNOWNEffectiveness of a Multidisciplinary Treatment and Structured Education ProgrammeNCT06184815 · lead sponsor · 2024-01-01
UNKNOWNAutologous Fat Infiltration Versus General Measures as Treatment in Radiodermatitis Induced for Radiotherapy in Breast Cancer PatientsNCT07023796 · lead sponsor · 2023-09-01
COMPLETEDCollagen-povidone for Diabetic Seniors' TenosynovitisNCT06396819 · lead sponsor · 2023-01-01
COMPLETEDEffect of Electroacupuncture on Sensitive Symptoms of Distal Diabetic Peripheral NeuropathyNCT05521737 · lead sponsor · 2021-11-01
UNKNOWNIncidence of Metabolic Syndrome in People Living With HIV Without ExperienCe to ART Who Start DoLutegravir Based-Regimen Compared With BictegrAvir Based-RegimeNNCT06629480 · lead sponsor · 2021-06-25
COMPLETEDMelatonin on Clock Genes in Parkinson's DiseaseNCT04287543 · lead sponsor · 2021-05-01
WITHDRAWNDapagliflozin Effects on Mayor Adverse Cardiovascular Events in Patients With Acute Myocardial Infarction (DAPA-AMI)NCT04717986 · lead sponsor · 2021-01-26
COMPLETEDEffect of Subcutaneous Polyvidone Collagen Treatment on Hand Recovery in Adult Rheumatoid Arthritis.NCT06656169 · lead sponsor · 2021-01-01
COMPLETEDInteractions Between Antihypertensive Drugs and Drugs Prescribed in the Emergency RoomNCT05140590 · lead sponsor · 2021-01-01
COMPLETEDComparison of Endoscopic Band Ligation Plus 24-hour Versus 72-hour Terlipressin TherapyNCT05331768 · lead sponsor · 2021-01-01
COMPLETEDEducational Intervention in the First 18 Months of Life to Prevent/Manage Obesity of Children After Gestational DiabetesNCT04493177 · lead sponsor · 2020-08-25
ACTIVE_NOT_RECRUITINGEffect of Parenteral Glutamine on Myocardial Injury and Inflammation BiomarkersNCT06065566 · lead sponsor · 2020-02-04
COMPLETEDEffect of Sodium Intake on Brain Natriuretic Peptide Levels in Patients With Heart FailureNCT03351283 · lead sponsor · 2017-11-22
COMPLETEDPain Comparison Whit Visual Analog Scale (EVA) Between Four Analgesic Methods During Trans Rectal Prostatic BiopsyNCT03442075 · lead sponsor · 2017-05-01
COMPLETEDGastric Plication in Mexican PatientsNCT03210207 · lead sponsor · 2016-09-01
COMPLETEDDexamethasone and Respiratory Function After MastectomyNCT02305173 · lead sponsor · 2014-11-01
COMPLETEDEffect of Dexamethasone in Postoperative Symptoms After Mastectomy for Breast CancerNCT01116713 · lead sponsor · 2009-06-01
COMPLETEDOmega-3 Supplementation in HIV Patients With Therapeutic Lifestyle Change Diet.NCT02537236 · lead sponsor · 2009-01-01
COMPLETEDMagnesium and Metabolic SyndromeNCT00603499 · lead sponsor · 2006-07-01
COMPLETEDDOR/TDF/3TC COmpared With BIC/FTC/TAF in ART-Naïve People Living With HIV and Overweight or ObesityNCT07075146 · collaborator · 2025-05-05
RECRUITINGEffects of Low-intensity Transcranial Magnetic Stimulation on Major Depressive Disorder, and on 5-hydroxyindoleacetic Acid and Brain-derived Neurotrophic Factor LevelsNCT06667180 · collaborator · 2024-10-28
RECRUITINGGenetic Bases of Neuroendocrine Neoplasms in Mexican PatientsNCT06523582 · collaborator · 2022-08-03
RECRUITINGCohort Study of Metabolic Disease and HypertensionNCT07577063 · collaborator · 2026-06-01
NOT_YET_RECRUITINGOnline Psychological Care Program for Women Who Attend a Breast Clinic.NCT05830461 · collaborator · 2023-10-19
UNKNOWNEffect of Moringa Oleifera Dehydrated Leaf Powder on the Components of Metabolic Syndrome in Mexican Adults.NCT07194577 · collaborator · 2023-01-05
COMPLETEDEffect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes MellitusNCT05467514 · collaborator · 2022-07-01
COMPLETEDCombined Antioxidant Therapy on Oxidative Stress, Mitochondrial Dysfunction Markers in Diabetic RetinopathyNCT03702374 · collaborator · 2018-09-26
COMPLETEDCell Therapy for Peripheral Arterial Disease and DiabetesNCT03635970 · collaborator · 2018-05-18
COMPLETEDSkin Ulcers Treatment With an Handicraft Topical DeviceNCT02512159 · collaborator · 2014-03-01
COMPLETEDAn Intervention for Elderly in Emergency ServicesNCT01706133 · collaborator · 2013-06-01
COMPLETEDEffect of Omega 3 Fatty Acids on Oxidative Stress in HIV Seropositive PatientsNCT02041520 · collaborator · 2013-01-01
COMPLETEDPolymorphisms of Interleukins, Glypican, and Human Leukocyte Antigen Genes and Treatment Response in Multiple Sclerosis.NCT02769767 · collaborator · 2012-08-01
UNKNOWNA Child Care-based Obesity Prevention InterventionNCT01679938 · collaborator · 2011-05-01
COMPLETEDEfficacy of Ubiquinone and Combined Antioxidant Therapy in Non-proliferative Diabetic RetinopathyNCT02062034 · collaborator · 2011-02-01
COMPLETEDVitamin D, C-reactive Protein and Insulin ResistanceNCT01019642 · collaborator · 2008-03-01
COMPLETEDPI Vs. NNRTI Based Therapy for HIV Advanced DiseaseNCT00162643 · collaborator · 2004-12-01
UNKNOWNDrugs studied in this sponsor's trials
8 mapped RxNorm conceptsThese drug records are connected through ClinicalTrials.gov studies listing Instituto Mexicano del Seguro Social as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.
placebo3
bictegravir1
cholecalciferol1
dapagliflozin 10 MG Oral Tablet1
liraglutide1
melatonin1
omega-3 fatty acids1
ubidecarenone1
placebo RxCUI 8375 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
3 trials
bictegravir RxCUI 1999660 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
cholecalciferol RxCUI 2418 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
dapagliflozin 10 MG Oral Tablet RxCUI 1488569 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
liraglutide RxCUI 475968 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
melatonin RxCUI 6711 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
omega-3 fatty acids RxCUI 4301 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
ubidecarenone RxCUI 21406 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
Sponsor roles
lead sponsor33
collaborator17
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.